Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03397173
Title TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Case Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cleveland Clinic, Case Comprehensive Cancer Center Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field